Speakers

Brandon Wood is an accomplished regulatory affairs leader with 13+ years of experience in the pharmaceutical industry, specializing in complex generic drug development. As Senior Director of Regulatory Affairs at Teva Pharmaceuticals USA, Inc. (Teva), Brandon leads a team of regulatory professionals responsible for the strategic planning, submission, and lifecycle management of complex generic applications. His portfolio includes products with complex active pharmaceutical ingredients (APIs), long-acting injectables, respiratory therapies, combination products, and non-sterile complex products.

Since joining Teva in 2018, Brandon has played a pivotal role in advancing regulatory strategies for high-barrier generics. Prior to Teva, he held progressive roles in regulatory and quality assurance within R&D at CorePharma and Impax Laboratories, where he supported both sterile and non-sterile product development. He began his career as a chemist at West-Ward Pharmaceuticals, contributing to raw material and bulk release testing, analytical research, data review, and technical investigations.

Brandon holds a Bachelor of Science in Chemistry with a concentration in Organic Chemistry from Monmouth University in West Long Branch, New Jersey.